Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe close: Stoxx 600 snaps nine-day win streak

(Sharecast News) - After a tentative start, European stock markets were firmly in the red on Thursday as investors chose to take profits following a nine-day winning streak that sent the Stoxx 600 index to record highs. The pan-European Stoxx 600 finished down 0.21% at 523.62, pulling back from Wednesday's all-time closing high of 524.71.

Almost every major benchmark index registered losses, with the exception of Madrid's FTSE MIB after a surprise drop in Italian inflation. Final estimates showed that annual inflation in Italy eased to 0.8% in April, down from 1.2% in March and below the preliminary estimate of 0.9%.

In other macro news, Japan's economy shrank more than expected in the first quarter as consumers tightened their belts in response to stagnant wage growth, companies cut spending and exports fell. GDP contracted 2% from last year, compared with a forecast decline of 1.2% and now clouds the outlook for the Bank of Japan's plans to lift interest rates.

Wall Street stocks were moving in a positive direction, as investors continued to react to the latest inflation figures out the previous session, which showed that price pressures eased in April.

"Investors have been pumped up by the latest inflation reading, believing it is cool enough to stir the Federal Reserve into action and cut rates in the near future," said Dan Coatsworth, investment analyst at AJ Bell.

"It also helps that quite a few US companies are getting a positive reaction to their latest results, together lifting the general mood around the markets and firing up enthusiasm to make trades."

European market movers

Roche reported positive trial results for its experimental weight loss treatment on Thursday, sending shares in the Swiss drugs group 3% higher. The firm said that over 24 weeks, the once-weekly injection had achieved "clinically meaningful and statistically significant" weight loss in healthy test subjects.

Stocks across the continent were providing a drag after going ex-dividend, meaning that from today shareholders would not have access to their latest payouts. These including BMW, Daimler Truck, GSK, Kingfisher, Tesco, Balfour Beatty, Unilever, BP and Shell.

French video game maker Ubisoft slumped 13% after disappointing the market with guidance for the current quarter.

Sage Group shares were down 9% in London as the accountancy software company downgraded its guidance despite reporting a robust first-half performance, while BT jumped 15% as it laid out plans to save £3bn of costs a year by the end of the decade.

Share this article

Related Sharecast Articles

Europe close: Stocks extend gains as Fed chief signals rate cuts lie ahead
(Sharecast News) - European stocks pushed higher still at the end of the week after the head of America's central bank clearly signalled that a first interest rate cut in the current cycle was coming in September.
Director dealings: Bluejay Mining non executive director ups stake
(Sharecast News) - Bluejay Mining revealed on Friday that non-executive director Roderick McIllree had acquired 7.5m ordinary shares in the AIM-listed exploration and development company.
London close: Stocks higher as investors digest Powell speech
(Sharecast News) - London markets closed in positive territory on Friday, as investors digested remarks from US Federal Reserve chairman Jerome Powell at the annual Jackson Hole economic symposium.
US open: Stocks higher following Powell's Jackson Hole speech
(Sharecast News) - Wall Street stocks were firmly in the green early on Friday as market participants turned their attention to Federal Reserve chairman Jerome Powell's remarks at the central bank's Wyoming economic symposium.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.